High-density lipoprotein and the acute phase response

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 2, 2010, Pages 156-160

  Jahangiri, Anisa ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

ATP binding membrane cassette transporter A1; Cholesteryl ester transfer protein; Endothelial lipase; Secretory phospholipase A2; Serum amyloid A

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTOKINE; HIGH DENSITY LIPOPROTEIN; SECRETORY PHOSPHOLIPASE A2; SERUM AMYLOID A; TRIACYLGLYCEROL LIPASE;

ACUTE PHASE RESPONSE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL TRANSPORT; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; KNOCKOUT MOUSE; LIPID RAFT; MOUSE; NONHUMAN; REVIEW;

ACUTE-PHASE REACTION; ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; LIPID METABOLISM; LIPOPROTEINS, HDL; MICE;

EID: 77749326468     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e328337278b     Document Type: Review

References (36)

1. Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007; 357:1301-1310.
2. Vaisar T, Pennathur S, Green PS, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007; 117:746-756.
3. Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res 2004; 95:764-772.
4. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005; 96:1221-1232.
5. Gelissen IC, Harris M, Rye KA, et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 2006; 26:534-540.
6. Rye KA, Bursill CA, Lambert G, et al. The metabolism and antiatherogenic properties of HDL. J Lipid Res 2009; 50 (Suppl):S195-S200.
7. Coetzee GA, Strachan AF, van der Westhuyzen DR, et al. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem 1986; 261:9644-9651.
8. Hoffman JS, Benditt EP. Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance. J Clin Invest 1983; 71: 926-934.
9. Stonik JA, Remaley AT, Demosky SJ, et al. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. Biochem Biophys Res Commun 2004; 321:936-941.
10. van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 2005; 280:35890-35895.
11. Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase is increased in vivo by inflammation in humans. Circulation 2008; 117:678-685.
12. McCoy MG, Sun GS, Marchadier D, et al. Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 2002; 43:921-929.
13. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004; 45:1169-1196.
14. Rohrer L, Hersberger M, von Eckardstein A. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 2004; 15:269-278.
15. Cheung MC, Brown BG, Marino Larsen EK, et al. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochim Biophys Acta 2006; 1762:131-137.
16. Masucci-Magoulas L, Moulin P, Jiang XC, et al. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. J Clin Invest 1995; 95:1587-1594.
17. Hardardottir I, Moser AH, Fuller J, et al. Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in syrian hamsters. J Clin Invest 1996; 97:2585-2592. (Pubitemid 26187346)
18. Lakomy D, Rebe C, Sberna AL, et al. Liver X receptor-mediated induction of cholesteryl ester transfer protein expression is selectively impaired in inflammatory macrophages. Arterioscler Thromb Vasc Biol 2009; 29:1923-1929.
19. Tam SP, Kisilevsky R, Ancsin JB. Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages. PLoS One 2008; 3:e3867.
20. Tam SP, Flexman A, Hulme J, Kisilevsky R. Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. J Lipid Res 2002; 43:1410-1420.
21. Jahangiri A, de Beer MC, Noffsinger V, et al. HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol 2009; 29:261-267.
22. Sullivan CP, Seidl S, Rich CB, et al. Secretory phospholipase A2, group IIA is a novel serum amyloid a target gene; Activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism. J Biol Chem 2009; 285:565-575.
23. de Beer MC, Webb NR, Whitaker NL, et al. SR-BI selective lipid uptake: subsequent metabolism of acute phase HDL. Arterioscler Thromb Vasc Biol 2009; 29:1298-1303.
24. Pussinen PJ, Malle E, Metso J, et al. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion. Atherosclerosis 2001; 155:297-305. (Pubitemid 32209299)
25. Hudgins LC, Parker TS, Levine DM, et al. A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 2003; 44:1489-1498.
26. Jaye M, Lynch KJ, Krawiec J, et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 1999; 21:424-428.
27. McGillicuddy FC, de la Llera Moya M, Hinkle CC, et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009; 119:1135-1145.
28. Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 2008; 28:2071-2077.
29. Zhu X, Lee JY, Timmins JM, et al. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem 2008; 283:22930-22941.
30. Yvan-Charvet L, Welch C, Pagler TA, et al. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 2008; 118:1837-1847.
31. Cimmino G, Ibanez B, Vilahur G, et al. Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by apoA-I. J Cell Mol Med 2009; 13:3226-3235.
32. Tang C, Vaughan AM, Anantharamaiah GM, Oram JF. Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1. J Lipid Res 2006; 47:107-114.
33. Tang C, Vaughan AM, Oram JF. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J Biol Chem 2004; 279:7622-7628.
34. Tang C, Liu Y, Kessler PS, et al. The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem 2009; 284:32336-32343.
35. King VL, Hatch NW, Chan HW, et al. A murine model of obesity with accelerated atherosclerosis. Obesity (Silver Spring) 2010; 18:35-41.
36. Poitou C, Divoux A, Faty A, et al. Role of serum amyloid a in adipocytemacrophage cross talk and adipocyte cholesterol efflux. J Clin Endocrinol Metab 2009; 94:1810-1817.